Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection.
Fiche publication
Date publication
juin 2021
Journal
Revue neurologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Bigaut K, Kremer L, Fleury M, Lanotte L, Collongues N, de Seze J
Lien Pubmed
Résumé
To analyze the humoral response after COVID-19 vaccination in patients with multiple sclerosis (MS) according to disease-modifying treatments (DMTs) and in comparison with the humoral response after SARS-CoV-2 infection.
Mots clés
Antibody, COVID-19, Humoral response, Multiple sclerosis, Vaccine
Référence
Rev Neurol (Paris). 2021 Jun 16;: